Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 15 de 15
Filtrar
1.
Atherosclerosis ; 391: 117478, 2024 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-38417185

RESUMEN

BACKGROUND AND AIMS: Atherosclerosis (AS) is a chronic inflammatory disease characterized by lipid infiltration and plaque formation in blood vessel walls. Ganoderic acids (GA), a class of major bioactive compounds isolated from the Chinese traditional medicine Ganoderma lucidum, have multiple pharmacological activities. This study aimed to determine the anti-atherosclerotic effect of GA and reveal the pharmacological mechanism. METHODS: ApoE-/- mice were fed a high-cholesterol diet and treated with GA for 16 weeks to induce AS and identify the effect of GA. Network pharmacological analysis was performed to predict the anti-atherosclerotic mechanisms. An invitro cell model was used to explore the effect of GA on macrophage polarization and the possible mechanism involved in bone marrow dereived macrophages (BMDMs) and RAW264.7 cells stimulated with lipopolysaccharide or oxidized low-density lipoprotein. RESULTS: It was found that GA at 5 and 25 mg/kg/d significantly inhibited the development of AS and increased plaque stability, as evidenced by decreased plaque in the aorta, reduced necrotic core size and increased collagen/lipid ratio in lesions. GA reduced the proportion of M1 macrophages in plaques, but had no effect on M2 macrophages. In vitro experiments showed that GA (1, 5, 25 µg/mL) significantly decreased the proportion of CD86+ macrophages and the mRNA levels of IL-6, IL-1ß, and MCP-1 in macrophages. Experimental results showed that GA inhibited M1 macrophage polarization by regulating TLR4/MyD88/NF-κB signaling pathway. CONCLUSIONS: This study demonstrated that GA play an important role in plaque stability and macrophage polarization. GA exert the anti-atherosclerotic effect partly by regulating TLR4/MyD88/NF-κB signaling pathways to inhibit M1 polarization of macrophages. Our study provides theoretical basis and experimental data for the pharmacological activity and mechanisms of GA against AS.


Asunto(s)
Aterosclerosis , Placa Aterosclerótica , Ratones , Animales , FN-kappa B/metabolismo , Factor 88 de Diferenciación Mieloide/metabolismo , Factor 88 de Diferenciación Mieloide/farmacología , Receptor Toll-Like 4/metabolismo , Aterosclerosis/tratamiento farmacológico , Aterosclerosis/prevención & control , Aterosclerosis/genética , Placa Aterosclerótica/metabolismo , Transducción de Señal , Macrófagos/metabolismo , Lípidos
2.
J Transl Med ; 21(1): 789, 2023 11 07.
Artículo en Inglés | MEDLINE | ID: mdl-37936202

RESUMEN

BACKGROUND: Prostate cancer (PCA) is the fifth leading cause of cancer-related deaths worldwide, with limited treatment options in the advanced stages. The immunosuppressive tumor microenvironment (TME) of PCA results in lower sensitivity to immunotherapy. Although molecular subtyping is expected to offer important clues for precision treatment of PCA, there is currently a shortage of dependable and effective molecular typing methods available for clinical practice. Therefore, we aim to propose a novel stemness-based classification approach to guide personalized clinical treatments, including immunotherapy. METHODS: An integrative multi-omics analysis of PCA was performed to evaluate stemness-level heterogeneities. Unsupervised hierarchical clustering was used to classify PCAs based on stemness signature genes. To make stemness-based patient classification more clinically applicable, a stemness subtype predictor was jointly developed by using four PCA datasets and 76 machine learning algorithms. RESULTS: We identified stemness signatures of PCA comprising 18 signaling pathways, by which we classified PCA samples into three stemness subtypes via unsupervised hierarchical clustering: low stemness (LS), medium stemness (MS), and high stemness (HS) subtypes. HS patients are sensitive to androgen deprivation therapy, taxanes, and immunotherapy and have the highest stemness, malignancy, tumor mutation load (TMB) levels, worst prognosis, and immunosuppression. LS patients are sensitive to platinum-based chemotherapy but resistant to immunotherapy and have the lowest stemness, malignancy, and TMB levels, best prognosis, and the highest immune infiltration. MS patients represent an intermediate status of stemness, malignancy, and TMB levels with a moderate prognosis. We further demonstrated that these three stemness subtypes are conserved across pan-tumor. Additionally, the 9-gene stemness subtype predictor we developed has a comparable capability to 18 signaling pathways to make tumor diagnosis and to predict tumor recurrence, metastasis, progression, prognosis, and efficacy of different treatments. CONCLUSIONS: The three stemness subtypes we identified have the potential to be a powerful tool for clinical tumor molecular classification in PCA and pan-cancer, and to guide the selection of immunotherapy or other sensitive treatments for tumor patients.


Asunto(s)
Neoplasias de la Próstata , Masculino , Humanos , Neoplasias de la Próstata/genética , Neoplasias de la Próstata/terapia , Pronóstico , Antagonistas de Andrógenos , Multiómica , Recurrencia Local de Neoplasia , Inmunoterapia , Microambiente Tumoral
3.
Medicine (Baltimore) ; 102(47): e36183, 2023 Nov 24.
Artículo en Inglés | MEDLINE | ID: mdl-38013356

RESUMEN

OBJECTIVE: To systematically evaluate the effects of lead therapies on percutaneous coronary intervention (PCI) after acute myocardial infarction (AMI). METHODS: A randomized controlled trial (RCT) in the CNKI, Wanfang, VIP, ProQuest, PubMed, Cochrane Library, Scopus, and Web of Science databases was searched until January 2023. Two researchers strictly screened and checked the included literature, extracted relevant data, and used the Cochrane Manual to assess the risk quality of the literature. Using RevMan 5.3 software, Meta-analysis of 4 main outcome measures [cardiac function-related indicators, 6-minute walking distance (6 MWT), quality of life (SF-36), Seattle angina pectoris scale (SAQ)], and 3 secondary outcome measures [adverse event incidence, death incidence, and readmission rate]. RESULTS: 22 studies were finally included with 1754 subjects, but the overall quality of the included studies was not high. The results of the meta-analysis showed that, in the cardiac function-related indicators compared to controls, improved left ventricular ejection fraction (LVEF) index (MD = 1.42, 95%CI [-0.94, 3.79], P < .00001); however, compared with the Baduanjin group, Tai Chi ball + Baduanjin group and control group, there was no significant difference (P > .05); compared with the control group, the guidance therapy group improved the left ventricular end-diastolic volume (LVEDV) index (MD = -4.67, 95%CI [-6.8, -2.71], P < .00001). In comparison, the lead group improved the 6 MWT (MD = 69.44, 95%CI [30.12, 108.76], P < .00001); the SF-36 score (MD = 10.05, 95%CI [8.68, 11.42], P < .00001])and the SAQ score (MD = 6.2, 95%CI [3.97, 8.44], P < .00001). Among the secondary outcome measures, the incidence of adverse events was statistically significant (RR = 0.17, 95%CI [0.1, 0.32], P < .00001); statistically significant (RR = 0.29, 95%CI (0.1, 0.87), P < .00001); readmission (RR = 0.39, 95%CI [0.17, 0.87, 0.89], P < .00001). CONCLUSION: Based on the current study, combining conventional therapy/ exercise or using simple lead therapy after PCI can improve the treatment effect and improve the quality of life.


Asunto(s)
Infarto del Miocardio , Intervención Coronaria Percutánea , Humanos , Infarto del Miocardio/tratamiento farmacológico , Angina de Pecho , Terapia por Ejercicio , Calidad de Vida , Ensayos Clínicos Controlados Aleatorios como Asunto
4.
J Neural Eng ; 20(2)2023 03 13.
Artículo en Inglés | MEDLINE | ID: mdl-36854181

RESUMEN

Objective. A motor imagery-based brain-computer interface (MI-BCI) translates spontaneous movement intention from the brain to outside devices. Multimodal MI-BCI that uses multiple neural signals contains rich common and complementary information and is promising for enhancing the decoding accuracy of MI-BCI. However, the heterogeneity of different modalities makes the multimodal decoding task difficult. How to effectively utilize multimodal information remains to be further studied.Approach. In this study, a multimodal MI decoding neural network was proposed. Spatial feature alignment losses were designed to enhance the feature representations extracted from the heterogeneous data and guide the fusion of features from different modalities. An attention-based modality fusion module was built to align and fuse the features in the temporal dimension. To evaluate the proposed decoding method, a five-class MI electroencephalography (EEG) and functional near infrared spectroscopy (fNIRS) dataset were constructed.Main results and significance. The comparison experimental results showed that the proposed decoding method achieved higher decoding accuracy than the compared methods on both the self-collected dataset and a public dataset. The ablation results verified the effectiveness of each part of the proposed method. Feature distribution visualization results showed that the proposed losses enhance the feature representation of EEG and fNIRS modalities. The proposed method based on EEG and fNIRS modalities has significant potential for improving decoding performance of MI tasks.


Asunto(s)
Interfaces Cerebro-Computador , Imaginación , Electroencefalografía/métodos , Encéfalo , Movimiento , Redes Neurales de la Computación , Algoritmos
5.
Food Funct ; 12(24): 12325-12337, 2021 Dec 13.
Artículo en Inglés | MEDLINE | ID: mdl-34821902

RESUMEN

5-Fluorouracil (5-FU) is a chemotherapeutic drug with a good anti-cancer effect on various types of cancers, such as colorectal cancer and breast cancer. However, previous studies have found that 5-FU could induce cognitive deficit in clinics. As ganoderic acid, isolated from Ganoderma lucidum, has a protective effect on neurons, this study investigated the effects of ganoderic acid (GA) against 5-FU-induced cognitive dysfunction with a series of behavioral tests and related indicators. Experimental results showed that GA significantly prevented the reduction of spatial and non-spatial memory in 5-FU-treated mice. In addition, GA not only ameliorated the damage to hippocampal neurons and mitochondrial structure, but also significantly improved abnormal protein expression of mitochondrial biogenesis related marker PGC-1α, and mitochondrial dynamics related markers MFN2, DRP1 and FIS1 in the hippocampi of 5-FU-treated mice. Moreover, GA could up-regulate the expression of neuronal survival and growth-related proteins, such as BDNF, p-ERK, p-CREB, p-Akt, p-GSK3ß, Nrf2, p-mTOR, and p-S6, in the hippocampi of 5-FU-treated mice. These results suggest that GA could prevent cognitive dysfunction in mice treated with 5-FU via preventing mitochondrial impairment and enhancing neuronal survival and growth, which provide evidence for GA as a promising adjunctive therapy for chemotherapy related cognitive impairment in clinics.


Asunto(s)
Disfunción Cognitiva/prevención & control , Fármacos Neuroprotectores/farmacología , Reishi , Triterpenos/farmacología , Animales , Antineoplásicos/efectos adversos , Modelos Animales de Enfermedad , Fluorouracilo/efectos adversos , Masculino , Aprendizaje por Laberinto/efectos de los fármacos , Ratones , Ratones Endogámicos BALB C , Neuronas/efectos de los fármacos , Fármacos Neuroprotectores/uso terapéutico , Fitoterapia , Distribución Aleatoria , Triterpenos/uso terapéutico
6.
Ageing Res Rev ; 70: 101394, 2021 09.
Artículo en Inglés | MEDLINE | ID: mdl-34139338

RESUMEN

Intervertebral disc degeneration (IDD) is a common degenerative disease of the musculoskeletal system that develops with age. It is regarded as the main cause of chronic low back pain in the elderly. IDD has various causes, including ageing, mechanical overloading, and nutritional deficiency. Melatonin is a pleiotropic indole hormone secreted by the pineal gland and plays an important role in resisting various degenerative diseases. The serum levels of melatonin decline with age and are reported to be negatively correlated with the symptomatic and histopathological scores of IDD. In vivo studies have shown that exogenous administration of melatonin could maintain the structural integrity of the intervertebral disc and inhibit the development of IDD. Mechanistically, by interacting with its membrane or intracellular receptors, melatonin can promote autophagic flux, scavenge free radicals, inhibit the release of pro-inflammatory factors, and block apoptotic pathways, thereby enhancing anti-stress abilities and matrix anabolism in different types of disc cells. Therefore, melatonin supplementation may be a promising therapeutic strategy for IDD. This review aimed to summarize the latest findings regarding the therapeutic potential of melatonin in IDD.


Asunto(s)
Degeneración del Disco Intervertebral , Disco Intervertebral , Melatonina , Núcleo Pulposo , Anciano , Humanos , Degeneración del Disco Intervertebral/tratamiento farmacológico , Melatonina/uso terapéutico
7.
Am J Chin Med ; 49(5): 1093-1114, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-34107859

RESUMEN

Idiopathic pulmonary fibrosis (IPF), a tumor-like disease, is a serious and fatal pulmonary inflammatory condition usually characterized by irreversible destruction of the lung parenchyma, excessive matrix accumulation, and decline in lung function. IPF still remains a great burden to the universe. At the moment, the available therapeutic regimens utilized for IPF such as non-pharmacological therapies (lung transplantation) and pharmacological therapies (drugs, nintedanib, pirfenidone, etc.) are normally accompanied by significant limitations, such as adverse reactions, low bioavailability, poor selectivity, low-tissue distribution, in vivo instability, systemic toxicity, inconveniency and unsafe usage. There is a need for the exploration and discovery of new novel remedies by researchers and scientists globally. Recent numerous preliminary studies have laid significant emphasis and demonstrated the antifibrotic importance, good curative actions (little or no adverse reactions), and multiple target sites of the active components from traditional herbal medicine (THM) against IPF, which could serve as a modern, alternative and potential therapeutics or drug candidates in treating IPF. This paper extensively summarizes the pharmacological actions and signaling pathways or mechanisms of active components obtained from THM for treating IPF. Moreover, the sources and modernization, markets, relevant FDA and CFDA studies (the USA and China), preclinical analysis, and various compositions of THM currently under clinical trials are also highlighted. Additionally, this present analytical data would be instrumental towards further drug progression or advancement of active components from THM for the potential therapeutics of IPF in the future.


Asunto(s)
Medicina de Hierbas/métodos , Fibrosis Pulmonar Idiopática/tratamiento farmacológico , Medicina Tradicional/métodos , Fitoterapia/métodos , Humanos , Plantas Medicinales
8.
Biomed Pharmacother ; 133: 111072, 2021 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-33378971

RESUMEN

Idiopathic pulmonary fibrosis (IPF) is a progressive pulmonary interstitial inflammatory disease of unknown etiology, and is also a sequela in severe patients with the Coronavirus Disease 2019 (COVID-19). Nintedanib and pirfenidone are the only two known drugs which are conditionally recommended for the treatment of IPF by the FDA. However, these drugs pose some adverse side effects such as nausea and diarrhoea during clinical applications. Therefore, it is of great value and significance to identify effective and safe therapeutic drugs to solve the clinical problems associated with intake of western medicine. As a unique medical treatment, Traditional Chinese Medicine (TCM) has gradually exerted its advantages in the treatment of IPF worldwide through a multi-level and multi-target approach. Further, to overcome the current clinical problems of oral and injectable intakes of TCM, pulmonary drug delivery system (PDDS) could be designed to reduce the systemic metabolism and adverse reactions of the drug and to improve the bioavailability of drugs. Through PubMed, Google Scholar, Web of Science, and CNKI, we retrieved articles published in related fields in recent years, and this paper has summarized twenty-seven Chinese compound prescriptions, ten single TCM, and ten active ingredients for effective prevention and treatment of IPF. We also introduce three kinds of inhaling PDDS, which supports further research of TCM combined with PDDS to treat IPF.


Asunto(s)
COVID-19/complicaciones , Medicamentos Herbarios Chinos/uso terapéutico , Fibrosis Pulmonar Idiopática/tratamiento farmacológico , Medicina Tradicional China/métodos , Fitoterapia , Composición de Medicamentos , Medicamentos Herbarios Chinos/administración & dosificación , Medicamentos Herbarios Chinos/química , Historia del Siglo XV , Historia del Siglo XVI , Historia del Siglo XVII , Historia del Siglo XVIII , Historia del Siglo XIX , Historia del Siglo XX , Historia Antigua , Historia Medieval , Humanos , Fibrosis Pulmonar Idiopática/etiología , Fibrosis Pulmonar Idiopática/prevención & control , Medicina Tradicional China/historia , Nebulizadores y Vaporizadores , Terapia Respiratoria
9.
J Ethnopharmacol ; 260: 112995, 2020 Oct 05.
Artículo en Inglés | MEDLINE | ID: mdl-32497674

RESUMEN

ETHNOPHARMACOLOGICAL RELEVANCE: the root of Stephania tetrandra S. Moore, known as Fangji in China (Chinese: ), is a traditional Chinese medicine (TCM) with a long history of use. Fangji is a type of medicine used to treat various diseases, including rheumatism, arthralgia, edema and beriberi, unfavorable urination, and eczema. AIM OF THIS REVIEW: There are many newly published reports on the history of uses, phytochemistry, pharmacological activity, quality control and toxicity of Fangji; however, no comprehensive systematic review exists. Therefore, the purpose of this review is to compile the latest and most comprehensive information on Fangji and provide a scientific basis for future research. MATERIALS AND METHODS: A systematic literature search was conducted using multiple electronic databases, including SciFinder, Web of Science, PubMed, Science Direct, ACS Publications, J-stage, SpringerLink, Thieme, Wiley, and CNKI. Information was also collected from journals and Chinese Pharmacopoeia. RESULT: Thus far, there were uses of Fangji against 20 different diseases/disorders, such as relieving edema and rheumatism pain, treating cough and asthma, treating enuresis, astringent urine and beriberi edema, purging blood and damp heat, and dispelling wind evil and dampness, etc. 48 compounds have been isolated from Fangji, belonging to alkaloids, flavonoids, and steroids, other compounds. The crude extracts and isolated compound of Fangji have shown a wide range of pharmacological activities, such as anti-tumor, anti-inflammatory, and neuroprotective activities, as well as role in reoxygenation, and antimicrobial effect, etc. Moreover, qualitative and quantitative analyses of quality control are reviewed, including qualitative analyses for the identification of compounds, as well as fingerprint and quantitative analyses by high performance liquid chromatography (HPLC) and capillary electrochromatography (CE). In the toxicity study, the hepatotoxicity, hepatorenal toxicity, nephrotoxicity, subacute and acute toxicities of the alcohol extract and water extract of Fangji, and tetrandrine were studied in-vitro and in-vivo experiments. CONCLUSION: In the history of uses, Fangji can be used to treat a variety of diseases, most of which are manifested in removing wind and dampness. In recent years, the phytochemistry of Fangji has rarely been reported. The pharmacological activities of Fangji mainly focus on the compounds, tetrandrine and fangchinoline, and there are a few reports on the pharmacological studies of other compounds in Fangji. Moreover, the quality control of Fangji lacks a standard fingerprint to distinguish Fangji from other easily-confused medicinal materials. In the toxicity study, there is no report on the mechanism of toxicity research. Therefore, further studies on such mechanisms are needed.


Asunto(s)
Medicamentos Herbarios Chinos/farmacología , Extractos Vegetales/farmacología , Stephania tetrandra/química , Animales , Medicamentos Herbarios Chinos/efectos adversos , Medicamentos Herbarios Chinos/química , Humanos , Medicina Tradicional China , Extractos Vegetales/efectos adversos , Extractos Vegetales/química , Raíces de Plantas , Control de Calidad
10.
Zhongguo Zhong Yao Za Zhi ; 44(4): 796-802, 2019 Feb.
Artículo en Chino | MEDLINE | ID: mdl-30989894

RESUMEN

Catalpol is an iridoid glycoside extracted from the root of Rehmannia glutinosa. It has been reported to have antioxidant stress effects. Adenosine 5' monophosphate-activated protein kinase( AMPK) plays an important role in inhibiting oxidative stress. This study was designed to investigate the protective effects of catalpol on TNF-α-exposed human aorta epithelial cells( HAECs) via inhibit oxidative stress,and the relationship between catalpol and AMPK was detected by RNA interference technique. Levels of superoxide dismutase( SOD),malonaldehyde( MDA),glutathione( GSH) and lactate dehydrogenase( LDH) were measured with a colorimetric assay kit. The level of ROS was measured with FACS calibur. Western blot was employed to detect the protein expression of AMPK,phosphorylated-AMPK and NOX4. Finally,RNA interference technique was used to investigate the role of AMPK in catalpol-induced protective effects. TNF-α treatment decreased the expression of phosphorylated-AMPK protein level,however,catalpol could reverse the decreased phosphorylated-AMPK level. Catalpol could inhibit NOX4 protein expression and decrease ROS overproduction. After using AMPK siRNA that effects of catalpol on ROS overproduction and NOX4 protein expression inhibition were attenuated. The above results suggest that catalpol inhibits oxidative stress in TNF-α-exposed HAECs by activating AMPK.


Asunto(s)
Glucósidos Iridoides/farmacología , Humanos , Iridoides , Estrés Oxidativo , Especies Reactivas de Oxígeno , Factor de Necrosis Tumoral alfa
11.
Clin Exp Metastasis ; 32(4): 323-33, 2015 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-25749878

RESUMEN

Bone is one of the most common sites for metastasis in breast cancer (BC). Micro-metastasis in bone marrow was detected in 30% of patients with stage I, II, or III BC at primary surgery and is a strong indicator of poor prognosis. The role dietary soy isoflavones play in BC with bone micro-metastasis is unclear. In this study, we examined the effects of genistein, daidzein, (-)-equol or a mixture of soy isoflavones on BC with bone micro-metastasis using an experimental model of murine mammary cancer 4T1 cells engineered with luciferase. A small number (1000) of 4T1 cells were injected into the tibia of female Balb/c mice to establish micro-tumors in bone. Soy isoflavones were supplemented in the AIN-93G diet at 750 mg/kg and were provided to mice from 3 weeks before to 3 weeks after cell injection. Bioluminescent imaging was conducted on day 2 (D2), D6, D8, D16 and D20 post cell injection and the results indicated dietary soy isoflavones enhanced the growth of bone micro-tumors on D8. Furthermore, dietary soy isoflavones stimulated metastatic tumor formation in lungs and increased Ki-67 protein expression in these metastasized tumors. In vitro, soy isoflavones (<10 µM) had limited effects on the growth, motility or invasion of 4T1 cells. Thus, the in vivo stimulatory effect could be likely due to systemic effects between the host, 4T1 tumors and soy isoflavones. In conclusion, soy isoflavones stimulate BC with bone micro-metastasis in mice and further investigations are needed regarding their consumption by BC survivors.


Asunto(s)
Neoplasias Óseas/tratamiento farmacológico , Neoplasias de la Mama/tratamiento farmacológico , Isoflavonas/sangre , Isoflavonas/farmacología , Neoplasias Pulmonares/tratamiento farmacológico , Animales , Anticarcinógenos/farmacología , Neoplasias Óseas/mortalidad , Neoplasias Óseas/secundario , Neoplasias de la Mama/mortalidad , Neoplasias de la Mama/patología , Proliferación Celular/efectos de los fármacos , Dieta , Suplementos Dietéticos , Modelos Animales de Enfermedad , Equol/sangre , Equol/farmacología , Femenino , Genisteína/sangre , Genisteína/farmacología , Isoflavonas/administración & dosificación , Antígeno Ki-67/metabolismo , Neoplasias Pulmonares/secundario , Ratones , Ratones Endogámicos BALB C , Invasividad Neoplásica/patología , Trasplante de Neoplasias , Pronóstico , Distribución Aleatoria , Alimentos de Soja
12.
Mol Nutr Food Res ; 59(8): 1419-30, 2015 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-25820259

RESUMEN

SCOPE: Soy flour diet (MS) prevented isoflavones from stimulating MCF-7 tumor growth in athymic nude mice, indicating that other bioactive compounds in soy can negate the estrogenic properties of isoflavones. The underlying signal transduction pathways to explain the protective effects of soy flour consumption were studied here. METHODS AND RESULTS: Ovariectomized athymic nude mice inoculated with MCF-7 human breast cancer cells were fed either Soy flour diet (MS) or purified isoflavone mix diet (MI), both with equivalent amounts of genistein. Positive controls received estradiol pellets and negative controls received sham pellets. GeneChip Human Genome U133 Plus 2.0 Array platform was used to evaluate gene expressions, and results were analyzed using bioinformatics approaches. Tumors in MS-fed mice exhibited higher expression of tumor growth suppressing genes ATP2A3 and BLNK and lower expression of oncogene MYC. Tumors in MI-fed mice expressed a higher level of oncogene MYB and a lower level of MHC-I and MHC-II, allowing tumor cells to escape immunosurveillance. MS-induced gene expression alterations were predictive of prolonged survival among estrogen-receptor-positive breast cancer patients, whilst MI-induced gene changes were predictive of shortened survival. CONCLUSION: Our findings suggest that dietary soy flour affects gene expression differently than purified isoflavones, which may explain why soy foods prevent isoflavones-induced stimulation of MCF-7 tumor growth in athymic nude mice.


Asunto(s)
Antineoplásicos Fitogénicos/administración & dosificación , Neoplasias de la Mama/dietoterapia , Regulación Neoplásica de la Expresión Génica , Isoflavonas/administración & dosificación , Proteínas de Neoplasias/metabolismo , Fitoestrógenos/administración & dosificación , Alimentos de Soja/análisis , Antineoplásicos Fitogénicos/efectos adversos , Antineoplásicos Fitogénicos/análisis , Antineoplásicos Fitogénicos/uso terapéutico , Neoplasias de la Mama/metabolismo , Neoplasias de la Mama/patología , Análisis por Conglomerados , Biología Computacional , Femenino , Perfilación de la Expresión Génica , Genisteína/administración & dosificación , Genisteína/efectos adversos , Genisteína/análisis , Genisteína/uso terapéutico , Humanos , Isoflavonas/efectos adversos , Isoflavonas/análisis , Isoflavonas/uso terapéutico , Células MCF-7 , Proteínas de Neoplasias/agonistas , Proteínas de Neoplasias/antagonistas & inhibidores , Proteínas de Neoplasias/genética , Análisis de Secuencia por Matrices de Oligonucleótidos , Ovariectomía , Fitoestrógenos/efectos adversos , Fitoestrógenos/análisis , Fitoestrógenos/uso terapéutico , Distribución Aleatoria , Carga Tumoral , Ensayos Antitumor por Modelo de Xenoinjerto
13.
Eur J Med Res ; 18: 16, 2013 Jun 05.
Artículo en Inglés | MEDLINE | ID: mdl-23738715

RESUMEN

BACKGROUND: Recent studies haveshown that ginsenoside Rg1, extracted from the dry roots of Panax notoginseng as a traditional Asian medicine, plays an anti-fibrosis role in myocardial remodeling. However, the mechanism still remains unclear. In the present study, we investigate the effect of ginsenoside Rg1on the collagenic remodeling of myocardium in chronic thromboembolic pulmonary hypertension (CTEPH), and its potential mechanism. METHODS: A rat model of CTEPH was established by injecting thrombi through the jugular vein wice in2 weeks. Four weeks later, four groups (Group A: normal rats + normal saline; Group B: normal rats + Rg1; Group C: CTEPH model + normal saline; Group D: CTEPH model + Rg1) were established. Normal saline and Rg1 were administrated by intraperitoneal injection. Ineach group, we measured the hemodynamic parameters, as well as the right ventricle to left ventricle (RV/LV) thickness ratio. Myocardial tissue sections of the RV were stained by hematoxylin-eosin +gentian violet and the morphological characteristics were observed by light microscopy. The matrix metalloproteinases (MMP) -2 and -9 were detected by the western blot. RESULTS: Compared with Group A and Group B, the right ventricular systolic pressure was significantly increased in Group C and significantly decreased in Group D. Compared with Group A and Group B, the RV/LV thickness ratio of the rats was significantly higher in Group C and Group D. There was significant fibrosis with collagen in Group C compared with Group A and Group B, and less significant changes in Group D were observed compared with those in Group C. The expression of MMP-2 and MMP-9 exhibited a significant decrease in Group C and was also significantly decreased in Group D compared withGroup A and Group B. Also, a negative linear relationship was shown between collagen-I and the expression of MMP-2 and MMP-9. CONCLUSIONS: Our animal study showed that ginsenoside Rg1 positively affects myocardial remodeling and pulmonary hemodynamics in CTEPH. Upregulation of the expression of MMP-2 and MMP-9 could explain the beneficial effects of ginsenoside Rg1 in CTEPH.


Asunto(s)
Regulación de la Expresión Génica/efectos de los fármacos , Ginsenósidos/administración & dosificación , Hipertensión Pulmonar/tratamiento farmacológico , Embolia Pulmonar/tratamiento farmacológico , Animales , Modelos Animales de Enfermedad , Ginsenósidos/química , Ventrículos Cardíacos/efectos de los fármacos , Ventrículos Cardíacos/fisiopatología , Humanos , Hipertensión Pulmonar/fisiopatología , Metaloproteinasa 2 de la Matriz/metabolismo , Metaloproteinasa 9 de la Matriz/metabolismo , Panax notoginseng/química , Embolia Pulmonar/fisiopatología , Ratas , Remodelación Ventricular/efectos de los fármacos
14.
Br J Nutr ; 109(1): 33-42, 2013 Jan 14.
Artículo en Inglés | MEDLINE | ID: mdl-22716201

RESUMEN

The present study aimed to explore the role(s) of the soya isoflavone genistein (GEN) in preventing the development of colon pre-neoplasia, using Wingless/int (WNT)/ß-catenin as a molecular marker of colon abnormality. Specifically, the effects on the WNT/ß-catenin signalling pathway from GEN were examined by using an azoxymethane (AOM)-induced rat colon cancer model. Male Sprague-Dawley rats were fed a control (CTL), a soya protein isolate (SPI) or a GEN diet from gestation to 13 weeks of age. The first sampling was conducted at 7 weeks of age for pre-AOM analysis. The remaining rats were injected with AOM at 7 weeks of age. The descending colon was collected 6 weeks later for the evaluation of aberrant crypt foci (ACF), gene expression and nuclear protein accumulation. AOM injection induced aberrant nuclear accumulation of ß-catenin in the CTL group but not in the SPI or GEN group. Moreover, the WNT target genes Cyclin D1 and c-Myc were repressed by SPI and GEN. Meanwhile, SPI and GEN suppressed the expression of WNT signalling genes including Wnt5a, Sfrp1, Sfrp2 and Sfrp5 to the similar level to that of the pre-AOM period. Rats fed SPI and GEN had a decreased number of total aberrant crypts. GEN feeding also resulted in a reduced number of ACF with N = 3 per foci. The reduction of WNT/ß-catenin signalling was correlated with the decrease in total aberrant crypts. By testing WNT/ß-catenin signalling as a biomarker of colon carcinogenic potential, we showed the novel role of GEN as a suppressor of carcinogen-induced WNT/ß-catenin signalling in preventing the development of early colon neoplasia.


Asunto(s)
Colon Descendente/metabolismo , Neoplasias del Colon/prevención & control , Modelos Animales de Enfermedad , Regulación hacia Abajo , Genisteína/uso terapéutico , Lesiones Precancerosas/prevención & control , Vía de Señalización Wnt , Focos de Criptas Aberrantes/metabolismo , Focos de Criptas Aberrantes/patología , Focos de Criptas Aberrantes/prevención & control , Animales , Azoximetano , Biomarcadores/metabolismo , Carcinógenos , Colon Descendente/patología , Neoplasias del Colon/metabolismo , Neoplasias del Colon/patología , Ciclina D1/genética , Ciclina D1/metabolismo , Femenino , Genisteína/metabolismo , Lactancia , Masculino , Fenómenos Fisiologicos Nutricionales Maternos , Lesiones Precancerosas/metabolismo , Lesiones Precancerosas/patología , Embarazo , Proteínas Proto-Oncogénicas c-myc/genética , Proteínas Proto-Oncogénicas c-myc/metabolismo , Ratas , Ratas Sprague-Dawley , Proteínas de Soja/metabolismo , Proteínas de Soja/uso terapéutico
15.
Huan Jing Ke Xue ; 29(6): 1526-32, 2008 Jun.
Artículo en Chino | MEDLINE | ID: mdl-18763495

RESUMEN

The characteristics of denitrifying phosphorus removal in a lab-scale two-sludge anaerobic-anoxic/nitrification SBR (A2 NSBR) system were studied fed with domestic wastewater. The influence of some key operation parameters, like C/P, C/N, and HRT, were examined using parallel tests, pH, dissolved oxygen (DO) and redox potential (ORP) were monitored on line to validate whether they could be used as the control parameters for this denitrifying phosphorus removal process. Results indicated that P removal efficiency showed an increased trend on the whole with the increase of the C/P. When the influent C/P was greater than 19.39, good phosphorus removal efficiency was achieved. However, the phosphorus removal efficiency deteriorated once the influent C/P decreased less than 15.36. On the other hand, relatively good phosphorus removal efficiency could be maintained in the A2 NSBR system even at a low C/N ratio, though the denitrification efficiency decrease instead. It is also found that increasing the influent C/N increased the PHB amount stored by polyphosphate accumulating organisms (PAO) and therefore the ultimate denitrification and phosphorus removal efficiency were both improved. For an excessively high C/N, the incompletely reacted COD will be residual to anoxic stage. Thus, the pure denitrification reaction, which preferentially supports OHOs, becomes the dominant reaction. This decreases the amount of available electron acceptors for denitrifying polyphosphate accumulating organisms (DNPAOs) at the anoxic stage which eventually impacts the anoxic phosphorus removal capacity. In addition, since A2 NSBR has two completely independent SBR systems, it benefits to establish a process control system in terms of the parameters DO, ORP, and pH.


Asunto(s)
Reactores Biológicos , Nitrógeno/aislamiento & purificación , Fósforo/aislamiento & purificación , Aguas del Alcantarillado/química , Eliminación de Residuos Líquidos/métodos , Bacterias Anaerobias/metabolismo , Biodegradación Ambiental , Nitrógeno/química , Nitrógeno/metabolismo , Fósforo/química , Fósforo/metabolismo , Aguas del Alcantarillado/microbiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA